Vaccines, Blood & Biologics
CBER FY 2012 Recall Postings
Class I recall: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
Class II recall: a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Class III recall: a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
| Allergenic | Blood | Blood Deriv. | Device | IVD | Source Plasma | Therapeutic | Tissue | Vaccine | Total Events by Class | |
|---|---|---|---|---|---|---|---|---|---|---|
| Class I | 1 | 1 | ||||||||
| Class II | 2 | 879 | 3 | 19 | 2 | 156 | 41 | 1 | 1,103 | |
| Class III | 3 | 275 | 4 | 13 | 8 | 245 | 12 | 7 | 567 | |
| Mixed Class (Cl. I/II) | 1 | 1 | ||||||||
| Mixed Class (Cl. I/III) | ||||||||||
| Mixed Class (Cl. II/III) | 121 | 1 | 1 | 123 | ||||||
| Total Events by Product | 5 | 1,275 | 7 | 33 | 10 | 401 | 55 | 8 | 1,794 |
Direct Recall Classification (DRC) Related Data 2012:
| Number of AI Requests during FY12 | 857 |
| Number of Alerts to Possible Recall sent during FY 12 | 67 |
| Number of DRC Recalls Classifed during FY 12 | 802 |







